In this episode of Accelerate Science Now, host Adeline DeYoung interviews Jason Kelly, co-founder and CEO of Ginkgo Bioworks, a leader in synthetic biology. They discuss the inspiration behind Ginkgo, the potential of programmable biology, and the challenges facing the biotech industry. Kelly emphasizes the importance of AI and automation in accelerating scientific discovery and the need for the U.S. to maintain its leadership in biotechnology amidst global competition. The conversation also touches on the future of health and the exciting possibilities that lie ahead in the field of bioengineering.